Important Things to Tell Your Clients About DJD

Horse owner knowledge about degenerative joint disease (DJD) varies. According to Sherry Johnson, DVM, MS, PhD, DACVSMR, senior partner at Equine Sports Medicine in Pilot Point, Texas/Scottsdale, Arizona, there are three things veterinarians can never overemphasize about DJD to their clients: 

1. What the early signs look like. 
2. DJD can develop at any age. 
3. There is no such thing as being too proactive when it comes to diagnosing DJD.

“The key to treating DJD is catching it early,” said Johnson. “When caught early and treated appropriately with a PSGAG like Adequan i.m.®, horses may experience significantly better outcomes.”

In this video brought to you by American Regent Animal Health, Johnson goes into more detail about why early recognition, diagnosis, and management of degenerative joint disease is so important for horses’ long-term soundness.

Adequan® i.m. polysulfated glycosaminoglycan (PSGAG) solution 100 mg/mL

INDICATIONS

Adequan® i.m. is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.

IMPORTANT SAFETY INFORMATION

There are no known contraindications to the use of intramuscular Polysulfated Glycosaminoglycan (PSGAG). Studies have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For additional safety information, please see full prescribing information at adequan.com.

Stay in the know! Sign up for EquiManagement’s FREE weekly newsletters to get the latest equine research, disease alerts, and vet practice updates delivered straight to your inbox.